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Summary 
Monoclonal antibody 3F12 identifies a cytoplasmic 
antigen of 49 kDa in human hippocampus and neocor- 
tex. The distribution of 3F12 immunoreactive neurons 
closely matches that of Alzheimer's disease (AD) tar- 
geted neurons in these areas. In some hippocampal 
neurons of AD patients, this antigen colocalizes with 
ALZ-50, indicating the presence of AD pathology in 
these neurons. Molecular characterization of the 3F12 
cDNA revealed it to be a member of the MAP kinase 
family, showing 43% amino acid sequence identity to 
human extracellular related kinase 2 (p42maP"). We have 
confirmed that p493F12 kinase autophosphorylates both 
threonine and tyrosine residues, as expected for a 
MAP kinase. The p49 mRNA is expressed exclusively 
in the nervous system. In the brain, the distribution of 
these neurons closely corresponds to 3F12 antigen- 
bearing neurons. The p493F12 gene maps to the human 
chromosome 21q21 region, a region that may be im- 
portant in the pathogenesis of AD and Down's syn- 
drome. 
Introduction 
The mitogen activated protein (MAP) kinases have emerged 
as key switch kinases that initiate a cascade of serine/ 
threonine phosphorylation signals (Ray and Sturgill, 1987; 
Payne et al., 1991). The evolutionarily conserved family 
of MAP kinases includes at least three vertebrate kinases: 
p42 mapk (extracellular elated kinase 2 [ERK2]), p44 rnapk 
(ERK1), and p55 ma~k (ERK3; Bou Iton et al., 1991 ). The cas- 
cade may also be activated in response to a variety of 
stimuli, such as those from G protein-coupled receptors 
(Gardner et al., 1993) and intracellular calcium mobiliza- 
tion (Chao et al., 1992). 
Although MAP kinases are expressed ubiquitously in 
vertebrate tissues, they appear to be enriched in neural 
tissues. Boulton et al. (1991) have shown that ERK1, 
ERK2, and ERK3 mRNAs are expressed at highest levels 
in the nervous system of adult rats, with ERK2 and ERK3 
displaying alternative patterns in certain brain regions. 
The human ERK3 (also known as p63 r"apk) shows high lev- 
els of expression in heart and brain (Gonzalez et al., 1992). 
MAP kinases may play a special role in terminally differ- 
entiated neurons. ERK1, ERK2, and ERK3 are all ex- 
pressed in adult neurons, indicating a role for these en- 
zymes other than in cell proliferation. There is also 
evidence indicating that MAP kinases may be regulated 
by nerve growth factor (NGF); NGF-dependent stimulation 
of neurite outgrowth in PC12 cells coincides with a 30-fold 
increase in MAP kinase activity and translocation of the 
kinase to the nucleus. Furthermore, MAP kinases may 
also be involved in the regulation of the NGF-induced G1 
arrest of PC12 cells (Rudkin et al., 1989). 
Several experiments uggest an involvement in the reg- 
ulation of cytoskeletal elements by MAP kinases. ERK1 
and ERK2 are associated with the microtubule organizing 
centers during meiotic maturation of mouse oocytes (Verl- 
hac et al., 1993). Disruption of microtubules by colchicine 
in rat fibroblasts leads to activation of a serine/threonine 
kinase similar in chromatographic properties to MAP ki- 
nases (Shinohara-Gotoh et al., 1991). 
Perturbations in the regulation of MAP kinases may be 
involved in pathological processes of human brain. In AIz- 
heimer's disease (AD), several neuronal cytoskeletal pro- 
teins have been shown to be abnormally phosphorylated 
(Arai et al., 1990). One of these proteins, microtubule- 
associated protein tau, is abundant in axons, where it sta- 
bilizes microtubules (Drechsel et al., 1992). Abnormally 
phosphorylated tau is the primary constituent of the neuro- 
fibrillary tangles (NFT), a pathological hallmark of AD 
(Goedert et al., 1989). MAP kinase is able to hyperphos- 
phorylate tau in vitro, causing it to acquire abnormal bio- 
chemical properties imilar to those found in AD NFTs (Lu 
et al., 1993). The ERK2 protein is immunocytochemically 
localized to NFTs and dystrophic neurites associated with 
senile plaques (Trojanowski et al., 1993). In vitro, ERK2 
is able to phosphorylate 14-16 proline-directe d serine or 
threonine residues on tau, whereas normal tau in adult 
brain has 2-3 phosphorylated sites (Drewes et al., 1992; 
Goedert et al., 1992). 
Although some kinase isozymes display regional and 
cell type specificity in the brain, no neuronal subset speci- 
ficity for any of the known serine/threonine kinases, in- 
cluding MAP kinases, has yet been reported. We pre- 
viously described neuronal su bset-specific expressiOn of 
a cytoplasmic protein immunoreactive with MAb 3F12 in 
a subpopulation of pyramidal neurons in the human hippo- 
campus and neocortex (Miller and Benzer, 1983; Miller et 
al., 1987; Hinton et al., 1988). Immunoblots of homoge- 
nates of human hippocampus detect four immunoreactive 
bands of 60, 49, 45, and 42 kDa. We also reported the 
loss of MAb 3F12 immunoreactivity in neurons of AD pa- 
tients early in the course of the disease. This pattern of loss 
corresponds, topographically, to the pattern of neuronal 
degeneration (Miller et al., 1987; Hinton et al., 1988). 
Here, we report the cloning and sequencing of the 
p493F12 cDNA and the identification and partial character- 
ization of its protein product that exhibits significant se- 
quence similarity to members of the MAP kinase family. 
This kinase is present in a subpopulation of neurons and 
can colocalize with the ALZ-50 antigen in AD hippocampal 
sections. Expression of the gene provides a marker for 
the subset of neurons targeted in AD. 
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Figure 1. Immunocytochemistry of MAb 3F12 
in Neurologically Normal Brain (Immunoper- 
oxidase) 
(A) Pyramidal neurons in the CA1 and CA2 re- 
gions of the hippocampus are labeled with MAb 
3F12. Note the sharp demarcation between 
staining in the CA1 region and its absence in 
CA2. Neurons are present in the CA2 region; 
however, they are not immunolabeled. Bar, 
0.1 mm. 
(B) The antigen is found in the somal cytoplasm 
as well as in proximal apical dendrite. Bar, 10 
p.m. 
(C) An axon in a hemotoxylin counterstained 
section of corpus callosum is densely immu- 
nolabeled (red HRP enzymatic product). Bar, 
10 ~m. 
Figure 2. Immunocytochemical Colocalization 
of p493F12 and ALZ-50 in Hippocampal Pyrami- 
dal Neurons of AD Patients 
(A) The 3F12 antigen is demonstrated by FITC 
in the cytoplasm of a pyramidal neuron in the 
CA1 region of the AD hippocampus. The sec- 
tion was viewed under e single pass filter for 
FITC. Lipofuschin appears bright yellow. 
(B) The 3F12 and ALZ-50 antigens demon- 
strated by FITC and Texas Red (arrows), re- 
spectively, are localized within the cytoplasm 
of the same AD hippocampal neuron. The sec- 
tion was viewed under a double pass filter for 
FITC and Texas Red. Lipofuschin appears 
bright yellow. Bar, 10 pm. 
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Results 
Immunocytochernical Characterization 
of the Antigen 
MAb 3F12 stained a subpopulation of pyramidal neurons 
in the CA4, CA1, and subiculum regions of the hippocam- 
pus and layers 3 and 5 of the neocortex in neurologically 
normal human brain. Staining was localized to somas and 
the proximal portions of apical dendrites (Figures 1A and 
1B). Some axons were labeled in the white matter of the 
cerebrum, spinal cord, and the brainstem (Figure 1C). 
Hippocampal sections from AD patients were double 
stained with MAbs 3F12 and ALZ-50. MAb ALZ-50 iden- 
tifies abnormally phosphorylated tau proteins and is a 
marker for early neurofibrillary degeneration in AD (Wo- 
Iozin et al., 1986). The 3F12 and AI 7-50 antigens, labeled 
with fluorescein isothiocyanate (FITC) and Texas Red, re- 
spectively, colocalized in some pyramidal neurons in the 
CA4, CA1, and subiculum regions. These results confirm 
that antigen 3F12 is expressed in neurons vulnerable in 
AD. The 3F12 antigen present in the somal cytoplasm and 
the proximal apical dendrites was displaced by punctate 
deposits immunoreactive with MAb ALZ-50 (Figures 2A 
and 2B). In some neurons, ALZ-50 staining was more ex- 
tensive and occupied the entire neuronal soma, with little 
to no remaining 3F12 reactivity. 
Molecular Cloning of the 3F12 cDNA 
We screened a human hippocampal Xgt11 cDNA expres- 
sion library with MAb 3F12. Among 300,000 plaques, 3 
positive clones were isolated with insert sizes of 450,420, 
and 351 bp. Each clone was labeled with 33p and hybrid- 
ized in situ to human hippocampal sections. Only one 
clone (HH3,351 bp) hybridized to a subpopulation of pyra- 
midal neurons in a distribution very similar to that of MAb 
3F12 immunoreactivity (Figures 3A-3F). DNA sequence 
analysis of this clone and comparison with sequences in 
GenBank revealed it to be novel. 
To obtain a full length cDNA clone, the 32P-labeled 351 
bp clone was used to screen a ZZAPII, oligo(dT)-primed 
human hippocampal library. After screening 150,000 
plaques, a 2.4 kb cDNA clone with an exact nucleotide 
sequence match with clone HH3 was isolated. The low 
abundance indicated that it was a rare mRNA species, in 
agreement with the low quantities of MAb 3F12 immunore- 
active proteins in hippocampal tissue homogenates. By 
primer extension, using an antisense primer hybridizing 
near the 5' end of the 2.4 kb cDNA, it was determined that 
this cDNA clone lacked 260 bases from the 5' untranslated 
region (UTR; data not shown). Nonetheless, it contained 
the complete amino acid coding sequence of the p493F~2 
kinase. The 2.4 kb cDNA clone labeled with 33p also hybrid- 
ized in situ to the same distribution of neurons as clone 
HH3. 
Sequence Analysis of the cDNA 
The nucleotide sequence of the clone revealed it to be 
2411 bp in length (Figure 4A). A continous open reading 
frame encoding 422 amino acids began at position 223. 
Three additional ATGs in the 5' UTR were all followed by 
in-frame stop codons. There was also a 3' UTR of 918 bp 
beginning at position 1492. A 34 bp poly(A) tail was present 
beginning at position 2372, with a possible polyadenyla- 
tion signal at position 2351. The Kyte-Doolittle hydropathy 
analysis of the predicted amino acid sequence did not 
reveal any extended hydrophobic regions that would sug- 
gest a membrane-spanning domain. A schematic repre- 
sentation of the p493r12 kinase domains indicates the pres- 
ence of the ATP-binding domain, two TXY phosphorylation 
sites separated by two valine residues and the serine/thre- 
onine catalytic sequence (Hanks et al., 1988) (Figure 4B). 
Nucleotide searches of the GenEMBL database using 
the blastn program revealed 75% identity with clone 
HFBCL46 (GenBank accession number M85653) begin- 
ning at position 14 and ending at position 373 of the 3F12 
cDNA sequence. Swiss-Pro protein database searches 
with 3F12 amino acid sequence did not match any known 
proteins; the 3F12 deduced protein sequence is novel. 
However, significant amino acid sequence homology to 
MAP serine/threonine kinases was observed. There was 
a 42% sequence identity between the predicted amino 
acid sequence of 3F12 cDNA and that of the human ERK2 
(p42maPk). A gap alignment of the kinase with human ERK1, 
ERK2, ERK3, and Saccharomyces cerevisiae LYT2 and 
FUS3 is shown in Figure 5A. The percent amino acid iden- 
tities among these kinases are shown in Figure 5B. 
Distribution of the mRNA 
Northern blots of human hippocampus, primary motor cor- 
tex (Brodmann's area 4), frontal association cortex (area 
10), primary visual cortex (area 17), cerebellum, spinal 
cord, and cerebral white matter were probed with a 32p. 
labeled 1.0 kb cDNA fragment, corresponding to the first 
1000 bases of the 2.4 kb cDNA clone (Figure 6A). A 2.7 
kb mRNA species was identified in the hippocampus and 
areas 4, 10, 17, the cerebellum, with a weak signal in the 
spinal cord. White matter, which lacks neuronal cell bod- 
ies, did not show expression of the mRNA, in keeping with 
the localization of the antigen to neurons. Furthermore, 
analysis of mRNA from other brain regions revealed ex- 
pression of the 2.7 kb mRNA in striatum and brain stem 
(Figure 6B). The expression of the 3F12 mRNA species 
was also examined in other tissues. In northern blots of 
poly(A) + mRNA from heart, placenta, lung, liver, skeletal 
muscle, kidney, pancreas, and testis, only kidney (Figure 
6C) and testis (Figure 6B) showed very weak hybridization 
to a 2.7 kb species. Other tissues showed no detectable 
expression (Figure 6C). 
Autophosphorylation of 3F12 MAP Kinase 
To test for phosphorylation activity of the p493F12 kinase, 
a plasmid (pTrcHis-3F12) was constructed in which the 
kinase was expressed as a 49 kDa fusion protein in Esche- 
richia coli after induction by isopropyl ~-D-thiogalacto- 
pyranoside (IPTG; Figure 7A). The fusion protein was puri- 
fied to >95% homogeneity for further analysis. 
Incubation of the recombinant p493F~2 kinase with buffer 
and [y-32P]ATP resulted in phosphorylation of the purified 
protein (Figure 7B). Heat inactivation of the pure protein 
before autophosphorylation prevented incorporation of 
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Figure 3. In Situ Localization of the p493F12 Kinase mRNA in Neurologically Normal Hippocampus 
Hippocampal sections were probed with ~P-labeled antisense (A and D) and sense (B and E) p493F12 cRNA probes generated from the full-length 
2.4 kb cDNA. A subpopulation of pyramidal neurons in the CA4, CA1, and subiculum regions of the hippocampus were labeled. ~,-APP ~P-labeled 
antisense cRNA probe was used to determine the integrity of mRNA on tissue sections (C). This probe hybridized to all neurons. Sections were 
viewed under dark field and light field, respectively. In dark field low magnification (A), silver grains are abundant over neurons in the CA1 region. 
A concentration of grains over CA1 pyramidal neurons counterstained with Giemsa are seen in light field at higher magnification (D). All slides 
were exposed to silver emulsion for 6 days at 4°C except I3-APP, which was exposed for 3 clays (C). A schematic of the human hippocampus 
delineates regions where neurons immunoreactive with MAb 3F12 (closed triangles) and neurons expressing p493F'2 kinase mRNA (closed circles) 
are located (F). An almost identical distribution of positive neurons is seen in both assays. Open triangles denote nonreactive neurons by immunocyto- 
chemistry or in situ hybridization. Note that in (B) and (E), a few grains are present over neurons, owing to background from long exposure times. 
Bars, 0.1 mm (A, B, and C); 10 ilm (D and E). 
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A 
l GAG~`TGG~GTGG~AGQGGACCCA~CGAGCCCAG~G~AT~TT~CC~TGCTTCCT~TACCCCTGTA~TTCACGCA~CTCTCT~TTGACTC~QCTC 99 
i00 CAGGCTAGTGTGAG~CACC~CAGCAGGCCCATCTCAGATCTTCACTATGGC~C~TATGC~GAAACTGTTG~TAGAC~CsTTTCCTATAGAT~ 198 
199 AGA~ACCATAC~GCT~TGGTATTTA~A~CCTCCATTTCTTA~ACTACTGCAGTG~=~CC~CA~TGGATGTGAAAA~TGCCTTTTQTCAGGGAT~CGA 297 
1 M S L H F L Y Y C S E P T L D V K I A F C Q G F D  24 
298 T~AAC~T~GA~TGTCA~A~AqTGCC~-~CATTAC~CA~AGC~AAGCAAAGTTGAC~CCAGT~CTACAGTGTGG~TGGQAGACTC~CCTT 39~ 
25 K Q V D V S Y I A K H Y N M S K S K V D N Q F Y S V E V G D S T F  87 
397 CACAG~TCTC~.GCGCTACCAG~TCT"A~GCCTATTGGCTCTGGGGCTCAGGGCATAG~TTGTGCCG~GTATGATGCTGTCCTT~ACAGAAAT~TGGC 49~ 
5 8 T V L K R y Q N L K P I G S G A Q G I V C A A y D A V L D K N V A  90 
496 CATT~G~GCTCAGCAGACCCT9TCAG~=CCAAACACATGCC~GAGAGC~TACCGGGAGCTGGTCCTCATG~GTGTG~G~CCATAAAAACATTAT 59~ 
91 I K K L S R P F Q N Q T H A K R A Y R E L V L M K C V N H K N I I  123 
595 TAGTTTATqAAATG~CqTCACACCCCAGAAAA~GCTGGAGGAGTTCC~GATGTT~ACTTAGT~TGG~CTGATGGATGCC~CT~AT~TC~GTGA~ 693 
124 S L L N V F T P Q K T L E E F Q D V Y L V M E L M D A N L C Q V I  156 
694 TCAGATGG~TTAGACCATGAGCQ~TG~C~TACCTGCTGTACCAAATGTTGTGT~CA~T~GCACCTCCATTCTGCT~G~-TTATTCACA~GATTT 792 
157 Q M E L D H E E M S Y L L Y Q M L C G Y K H L H S A G I I H R D L  189 
793 AAAACC~GT~CA?TGTAG~C~GTCTGATTGCACATTGA~AATCCT~ACT~GGAC~GGCCAGGACAGCAGGCAC~G~TCATGATGACTCCA~A 891 
1 9 0 E P S N I V V K S D C T L K I L D F G L A R T A G T S F M M T P y  222 
892 TGTGG~GACACGT~ATTACAGAGCCCCTGAG~CATC~TG~ATGGGCTAC~GGA~CGT~GATATATGGTCTGTGGGAT~CA~TATGGGAGAAAT 990 
223 V V ~ R Y y R A p E V I L G ~ G Y E E N V D I W S V G C I M G E M  255 
991 G~TTCGCCACAAAA~CCTCTTTC~AGG~GGGACTATATTGACC~G~G~T~GGT~TTG~C~CTAGG~CACCATGTCCAG~ATTCATG~G~ 1089 
2 5 6 V R H K i L F P G R D y I D Q W N K V I E Q L G T ~ C P E F M K K  288 
1090 ATTGC~CC~ACAG~GAAACTATGTGGAG~CGGCCC~GTATGCGGGACTCACC~CCCCA~ACTCTTCCCAGA~TCCCTCTTCCCAGC~GACTC 1188 
~89 L Q B T V R N Y V E N R P K y A G L T F p K L F p D S L F p A D S  32! 
i189 CGAGCAC~T~A~AC~C~GCCA~CC~GCCAGGGACTTGTTGTCAAAGATGC~AGTGATTGACCCAGCAA~AAG~TATCAGTGGACGACGCCTTACA 1287 
322 E H N K L K A S Q A R D L L S K M L V I D P A K R I S V D D A L Q  354 
1288 GCATC~C~ACATC~CGTCTGG~ATGACCCAGCCG~GTGsAGGCGCC~CCACCTCAGA~ATATGAC~GCAG~T~GATGAAAGAG~CACAC~qTGA 1386 
355 H P Y I N V W Y D p A E V E A P P ? Q I y D K Q L D E R E H T I E  387 
13~7 AG~-TQGAAAG~C~TATCTAC~G~GT~TG~TTCAG~GAAAAGACTAAAAATG~TGTAGT~A~GACAGCCTTCTCCTTCAGCACAGGTGCA 1485 
3 8 S E W K E L I Y K Z V M N S E E K T K N G V V K G Q P S P S A Q V Q  420 
1486 GCAG~CAGCAG~GA~AGTCTCCCTCCATCcTCGTCTGTC~T~ACATCTCCTCCATGTCCACCGACCAGACCCTGGCATCTGACACTGACAGCAGC 1584 
421 Q ~ 453 
15~5 CTG~GCCT~GGCAGGACCCCT~GGTTGTTGCAGG~GACTAGCCGCCTGCCTGCGA~ACCCAGCGT~CT~CAGGAGAT~ATGTGA~GG~CACACACA 1683 
!6~4 CACGCAGACACACA~ACACACACAAATGCAGACACAC~CA~C~GAAAACA~GGGAGAG~TCC~%GCCTAAAATTA~T~ATCTTTCAGCCTG 178~ 
~783 CTTCTTCCCCAGGGTTCTGTA~T~CAGCT~GCTCAAATGTATATTT~CTTCTAG~T~CTCTTGCTTTGGTCTTCTTCC~TGATGC~TACqACAG~ 1881 
1882 AGCAAATCAGACAC~TTAGA~GCCTTTTCCATAA~GTGT~TTT~TGGCTGCAAAACCGGC~CCTGT~CTGCCCT~TA~TGGCATGAC~ 1980 
19Sl GGTGT~CAGT~GCCCCATCCAGCATGTGTGTGTCTCTATCTTGCATCTACCTGCTCCT~GGCCTAGTCAGATG~ATGTAGATACAGATCCGCATGTG~C 2079 
2080 TGTATTCATACAGCACTACTTACT~AGAGA~GCTACTC~CAGTGTCCTCA~GCTCTACC~GACAT~TGCACTGGGGTACCACATGGTCCAT~TCAT 2178 
21P9 GTGATCTATTACTCTGACATAAAcCCATCTGT~TA~ATTGCCAGTATAT~GCTGTTT~GT~TGTT~TTGATTAAACTGTATGTCT~AT~GA~AAC 2277 
2278 ATGTA~a~GGGGG~-%~TATT~GGG~G~GAGCTCTCTCAGACCCTTG~m~ATGTAGCTTCCAAATTTG~T~ATT~TGGCACCTGTATACC~J~AAA 2376 
2377 ~ T C  TACGG 2411 
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Figure 4. Nucleotide and the Predicted Amino 
Acid Sequence of the p493F12 cDNA 
(A) The open reading frame extends from nu- 
cleotide 223 to 1492, encoding aprotein of 422 
amino acids. ATG of the initiation codon and 
the TGA of the termination codon are in bold 
lettering. The two TXY phosphorylation do- 
mains are underlined. A possible polyadenyla- 
tion signal in the 3' UTR is also underlined. 
(B) A domain map of p493F1~ kinase showing 
the amino acid sequences of conserved kinase 
subdomains. 
32p, thus discounting the possibility that tyrosine phosphor- 
ylation was due to a nonenzymatic reaction (Seger et al., 
1991). Phosphoamino acid analysis of the labeled protein 
revealed that phosphate was incorporated onto both tyro- 
sine and threonine residues (Figure 7C). The kinase was 
also autophosphorylated with cold ATP. It showed strong 
immunoreactivity with antibodies to phosphotyrosine on 
Western blots. Immunoreactivity could be blocked by the 
addition of excess phosphotyrosine (Figure 7D). 
Identification of the Kinase on Immunoblots 
Polyclonal antisera generated against the p49 bacterial 
recombinant protein (anti-p49)identified three immunore- 
active proteins of 49, 45, and 35 kDa in Triton X-100 solu- 
ble supernatants of human hippocampal homogenates 
(Figure 8B, lane 1). In a pure preparation of p49 bacterial 
fusion protein, anti-p49 immunoreactive bands of the 
same relative mobilities were identified, the band at 49 
kDa being the dominant form (Figure 8B, lane 2). MAb 
3F12 identified immunoreactive bands at 68, 49, 45, 42 
(doublet), and 35 kDa (Figure 8A, lane 1). The immunore- 
active bands of 49, 45, and 35 kDa comigrated with those 
identified by anti-p49. As expected, MAb 3F12 also re- 
acted with the p49 kinase fusion protein (Figure 8A, lane 
2). The no-primary-antibody control indicated the pres- 
ence of a 70 kDa band immunoreactive with the biotinyl- 
ated secondary antibody (Figure 8C, lane 1). However, 
this band was clearly distinct from the MAb 3F12 immuno- 
reactive band at 68 kDa. To confirm that anti-p49 and MAb 
3F12 recognize the same protein, we purified p49 from 
hippocampal homogenates by immunoaffinity chromatog- 
raphy using anti-p49. The immunopurified protein was 
probed on Western blots with MAb 3F12. Both anti-p49 
(Figure 8D, lane 1) and MAb 3F12 (Figure 8D, lane 2) 
recognized the same protein at 49 kDa. 
Chromosomal Mapping of the Gene 
To determine the chromosomal ocation of the p493F12 ki- 
nase gene, 32P-labeled 2.4 kb cDNA was used to probe 
Southern blots of hamster somatic hybrid lines. These cell 
lines harbor at least one human chromosome in addition 
to the hamster genome. Two unique bands at 5.5 and 2.3 
kb (the most intense bands on the blot) were identified in 
DNA from the cell line containing human chromosome 21 
(data not shown). For finer mapping, a 12.5 kb human 
genomic clone was isolated from a XFixll human genomic 
library by screening with 32P-labeled 2.4 kb cDNA probe. 
This clone was then biotin labeled by nick translation and 
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Figure 5. Amino Acid Comparison of p493F12 
with Other Proline-Directed Human Kinases 
(A) The alignment of the p493F'2 protein (top) 
with human ERK1 and ERK2, ERK3, S. cerevis- 
iae lyt2, and FUS3. p49 displays 41% and 43% 
amino acid sequence identity to human ERK1 
and ERK2, respectively, with the highest iden- 
tity in the kinase catalytic region. 
(B) Comparison of p493F~2 kinase deduced 
amino acid sequence with that of other MAP 
kinases. Percent identities are shown in the 
table. 
B 
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hybridized, along with a chromosome 21 specific cosmid 
probe, to human metaphase spreads by fluorescence in 
situ hybridization (FISH). Four fluorescent dots corre- 
sponding to areas of probe hybridization were observed 
on the q arm of chromosome 21 (Figure 9). The two most 
distal dots hybridized to the telomeric sequences of chro- 
mosome 21 as expected, since the cosmid is specific for 
these sequences. Two other fluorescent dots were ob- 
served at the approximate region of 21q21 (Figure 9, in- 
set). These were due to the p493F'2 probe, since spreads 
hybridized with the 21 specific cosmid alone showed only 
the two telomeric dots. The approximate location of the 
p493F12 gene was determined by the measurement of 
the relative distance from the most proximal portion of the 
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Figure 6. Northern Blot Analysis of p493F'2 Ki- 
nase mRNA 
(A) mRNAs (5 p.g) from each CNS site were 
probed with the 3F12 cDNA and exposed to 
X-ray film for 3 days. Lane 1, hippocampus; 
lane 2, area 4; lane 3, area 10; lane 4, area 17; 
lane 5, cerebellum; lane 6,spinal cord; lane 7, 
white matter. Note that a single 2.7 kb tran- 
script is seen in the hippocampus and all corti- 
cal sites, with none in the white matter. There is 
markedly lower abundance in the spinal cord. 
(B) mRNAs (5 p.g) from brain subcortical nuclei, 
brainstem, and testis were probed with 3F12 
cDNA and exposed to X-ray film for 3 days. 
Lane 1, caudate; lane 2, putamen; lane 3, nu- 
cleus basalis; lane 4, thalamus; lane 5, pons; 
lane 6, medulla; lane 7, testis. A 2.7 kb mRNA 
was identified in all sites. 
(C) mRNAs (2 p.g) from various human tissues 
were probed with 32P-labeled 3F12 cDNA and exposed to X-ray film for 6 days. Lane 1, heart; lane 2, brain; lane 3, placenta; lane 4, lung; lane 
5, liver; lane 6, skeletal muscle; lane 7, kidney; lane 8, pancreas. Note that other than in brain, there is hybridization close to threshold only in 
the kidney. Integrity of the mRNA was established by probing the blots with human ~-actin (lower panels). 
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Figure 7. Autophosphorylation of the Recombinant p493F~2 Kinase Protein 
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(A) p493F12 recombinant protein was produced in bacteria from a construct expressing all but 8 amino acids from the N terminus of the kinase. A 
49 kDa protein (containing a histidine tag) was purified from a bacterial lysate by nickel-agarose chromatography. Lane 1, uninduced bacterial 
lysate; lane 2, induced with IPTG; lane 3, purified p493F~2 kinase protein. Coomassie blue stain. 
(B) The p493F~ recombinant protein was incubated with [y-32P]ATP in kinase buffer, followed by the fractionation of the reaction products on 
SDS-PAGE and autoradiography. Lane 1, p493F~2 kinase heat inactivated prior to incubation; lane 2, untreated p493F~2 kinase; lane 3, bovine serum 
albumin. 
(C) Phosphoamino acid analysis of autophosphorylated p493F~2 kinase. Autophosphorylated protein was incubated in 6 M HCI and fractionated by 
thin-layer chromatography. The positions of phosphoserine, phosphothreonine, and phosphotyrosine were marked in an adjacent lane that contained 
these standards stained with ninhydrin. No 32P-labeled phosphoserine was present in the p493F~2 hydrolysate. Note that the twd lowest bands on 
the blot represent incompletely hydrolyzed protein. Arrow indicates the direction of migration. 
(D) Identification of the autophosphorylated p493F~2 kinase on Western blot with anti-phosphotyrosine antibodies. For lane 1, the autophosphorylated 
p49 kinase was fractionated on SDS-PAGE, transferred to nitrocellulose, and probed with MAb anti-phosphotyrosine; for lane 2, MAb anti- 
phosphotyrosine was preincubated with unlabeled phosphotyrosine. 
short arm to the area of probe hybridization and subse- 
quent comparison to a map of human chromosome 21. 
Discussion 
We have identified the 3F12 neuronal-specific antigen as 
a novel member of the MAP kinase family, partially con- 
firmed its function, and determined its expression in nor- 
mal human brain and in various somatic tissues. We have 
also shown that in brain tissues from patients with AD, MAb 
3F12 antigen colocalizes with MAb ALZ-50 in neurons with 
neurofibrillary pathology. In the human hippocampus, the 
kinase is distributed in subsets of neurons vulnerable in 
AD. Furthermore, we have mapped the location of the 
corresponding ene to the region of 21q21. 
In contrast o most MAP kinases described so far, which 
A B C 
1 2 1 2 1 
68 
49 
45 
42 
35 
,~ 'i ~ ,,~i~ .... 
,i,,':'i,i,~i,~iii,ii I I~~II ' 
ii,~'i",iiii II~II~I'IIIIIIII~II 
ii iiiiiiiill !,iiiiiii,~/ 
, i~ii i,i, ii~'ii~ '
D 
1 2 3 
Figure8. Immunochemical Identification of 
the p493F12 Kinase in Hippocampal Homoge- 
nares 
One gram of human hippocampus was homog- 
enized in buffer containing 0.1% Triton X-100 
and centrifuged at 100,000 x g. The superna- 
tant and a purified preparation of p493F~2 kinase 
fusion protein were fractionated by 10% SDS- 
PAGE and transferred to nitrocellulose. Lane 
1, hippocampus supernatant; lane 2, p493F12 
kinase fusion protein. 
(A) MAb 3F12 identifies immunoreactive bands 
at 68, 49, 45, 42 (doublet), and 35 kDa in hippo- 
campal supernatant (lane 1). MAb 3F12 also 
identifies the 49 kDa fusion protein (lane 2, 
arrow). 
(B) Anti-p49 identifies immunoreactive bands 
at 49 (arrow), 45, and 35 kDa in the supernatant 
and the fusion protein (lanes I and 2, respec- 
tively). 
(C) No primary antibody control indicated that 
the band at 70 kDa in the supernatant (migrating just above the 68 kDa band labeled by MAb 3F12 in [A]) is due to the nonspecific immunoreactivity 
of the secondary antibody (lane 1). No immunoreactivity is observed with the p493~12 kinase fusion protein (lane 2). 
(D) Western blot of immunoaffinity purified p49 from hippocampal homogenates. The blot was probed with the following: lane 1, anti-p49; lane 2, 
MAb 3F12; lane 3, no primary antibody. 
Neuron 
74 
Figure 9. Chromosomal Localization of the p493F~2 Kinase Gene by FISH 
The 12.5 kb p493 F12 human genomic lone and the chromosome 21-specific osmid probe were biotin labeled by nick translation and hybridized 
to human metaphase spreads. The probes were detected using streptavidin-FITC on chromosomes that were counterstained with propidium iodide. 
Low magnification shows specific hybridization of the p493F12 probe (two yellow-green dots) to the long arm of human chromosome 21 (arrow in 
the inset). The two distal dots are due to hybridization f the human chromosome 21-specific osmid probe to the telomeric region (arrowhead 
in the inset). 
(Inset) High magnification shows the region of hybridization tobe approximately 21q21 (arrow in the inset) as determined by measurement ofthe 
distance from the most distal portion of the short arm o the region of hybridization ofthe p49 probe. Bar, 10 p.m. 
are ubiquitously expressed, p493F~2 kinase expression is 
restricted to a subset of projection neurons in the nervous 
system. Analysis of the kinase mRNA by Northern blots 
and in situ hybridization in various human brain sites re- 
vealed expression in a subset of pyramidal neurons in the 
CA1 and subiculum regions of the hippocampus and in 
layers 3 and 5 of Brodmann's areas 4, 10, and 17 of the 
neocortex. Additionally, p493F~2 mRNA was detected in 
subcortical nuclei and brainstem. In nonneural tissues, 
only the testis and kidney showed markedly lower levels 
of expression. The lack of any detectable signal in the 
white matter poly(A) ÷ mRNA and the weak signal in the 
spinal cord is in agreement with the regional and neuronal 
specificity of the 3F12 antigen. To date, the sequence of 
the p493F~2 kinase is novel. However, a previously de- 
scribed cDNA (clone HFBCL46 [EST02170])from the 
dBEST library of sequences showed 75% identity with the 
3F12 nucleotide sequence. The relatively short clone of 
359 bp contains many alignment gaps and nucleotide mis- 
matches. Therefore, it is difficult o determine whether the 
p493F~2 kinase and HFBCL46 are the same clone. 
The kinases most closely related to p493F12 are rat ERK1 
and human ERK2, which show 41% and 43% amino acid 
sequence identity, respectively. Both of these kinases 
have been classified as members of the MAP kinase family 
and contain a tripeptide (TXY) in the kinase catalytic re- 
gion. Interestingly, the deduced amino acid sequence of 
p49 contains two TXY phosphorylation sites separated by 
two valine residues. This second site may be an additional 
regulatory element, providing for tighter control of the ac- 
tion of this kinase. Phosphopeptide mapping and site- 
directed mutagenesis studies have revealed that phos- 
phorylation of threonine and tyrosine residues in this 
tripeptide are required for maximal kinase activity; even 
conservative substitution of tyrosine residues reduces ac- 
tivity of the enzyme (Seger et al., 1991). Although Xenopus 
MAP kinase possesses weak autophosphorylation activity 
in vitro, deletion of its ATP-binding domain, which abol- 
ishes activity of the kinase, does not seem to interfere with 
phosphorylation of the tripeptide in vivo (Nakielny et al., 
1992). To ascertain the functional capacity of p493F12 ki- 
nase, we performed autophosphorylation assays with a 
bacterially produced fusion protein. This kinase pos- 
sesses weak autophosphorylation activity; the activity is 
real; it is abolished by exposure to temperatures of 55°C 
or higher. Incubations of 1 hr or more were required to 
generate a strong signal. Thus, p493F12 kinase resembles 
other MAP kin ases in that it does not readily autophosphor- 
ylate, suggesting that autophosphorylation may not be im- 
portant for its activation in vivo. 
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Our studies confirmed that the 49 kDa protein identified 
by both MAb 3F12 and anti-p49 is the neuronal protein. 
MAb 3F12 identified two additional proteins of 68 and 42 
kDa in hippocampal homogenates. Since these bands are 
not identified by anti-p49, it is likely that they constitute 
other related kinases or shared epitopes. The 45 and 35 
kDa bands, identified by both MAb 3F12 and anti-p49 in 
hippocampal homogenates, may be postmortem or pre- 
parative degradation products or differentially phosphory- 
lated forms of p493F12 kinase. Anti-p49 also identified 
bands with the same relative mobilities in the lane con- 
taining the purified fusion protein. Moreover, MAb 3F12 
identified immunoaffinity purified p49 from hippocampal 
homogenates. Anti-p49 was not immunoreactive on tissue 
sections of human hippocampal and frontal cortex. One 
possible explanation is the masking of epitopes in the na- 
tive conformation of the kinase in tissue. 
ERK1 and ERK2 are expressed in most neurons and 
reactive astrocytes in the human brain (Hyman, et al., 
1994). It is likely that these kinases are also expressed in 
the subset of neurons expressing p493F12 kinase. ERK1 
and ERK2 are regulated by activator kinases such as B-raf 
and MEK, which are not only expressed in dividing cells, 
but also in terminally differentiated neurons (Kyriakis et 
al., 1992). NGF stimulates the action of MAP kinases 
(Boulton et al., 1991) and the raf-1 protein kinase in PC12 
cells (Ohmichi et al., 1992). It would be intriguing to deter- 
mine whether raf-1 is also capable of activating p493F~2 
kinase. If so, a mechanism for selective activation of MAP 
kinases including p49 may exist, allowing targeting of 
these enzymes to various substrates. 
MAP kinases have been implicated in the phosphoryla- 
tion and activation of transcription factors such as c-myc 
(Seth et al., 1991). The mechanism of activation of these 
factors remains controversial; however, activation of MAP 
kinase in cells expressing these proteins results in in- 
creased expression of genes that contain promoter- 
binding sites for these factors. If p493F12 plays a role in 
activation of some of these factors, its subset specificity 
may provide an additional evel of regulation, resulting in 
increased or decreased expression of other genes within 
the MAb 3F12 immunoreactive subset. 
MAP kinases may also be involved in aberrant regulation 
of the neuronal cytoskeleton; they are capable of abnor- 
mally phosphorylating microtubule-associated protein tau 
at 14-16 proline-directed serine/threonine r sidues (Drewes 
et al., 1992). These events may be a precursor for the 
formation of the NFTs in AD. Localization of the p493F12 
kinase to axons and neuronal cell bodies of projection 
neurons (primarily affected in AD) may provide the oppor- 
tunity for interaction with tau or other cytoskeletal proteins. 
To date, none of the described MAP kinases are re- 
stricted in expression to areas containing tangle-bearing 
neurons. The role of MAP kinases in AD pathology, includ- 
ing the generation of paired helical filaments, has been 
examined in several laboratories. In biochemical studies, 
Xenopus MAP kinase converts normally phosphorylated 
microtubule-associated protein tau into an abnormally 
phosphorylated form recognizable with antibodies pecific 
for NFTs (Drewes et al., 1992; Goedert et al., 1992; Lu et 
al., 1993). MAP kinases that recognize proline-directed 
phosphorylation sites (e.g., ser-pro or thr-pro) seem to be 
better able to catalyze the transformation of normal tau 
into an abnormally phosphorylated form than are other 
kinases, such as Ca2+/calmodulin-dependent kinase (Ca/ 
CaM kinase) or protein kinase C I. 
The approximate location of the p493F12 kinase gene to 
the region of 21q21 may be significant in the pathogenesis 
of Alzheimers disease and Down's syndrome. The I~-amy- 
Ioid precursor protein (13-APP) gene has been mapped to 
the region of 21 ql 1.2-q21 (Tanzi et al., 1987) and the puta- 
tive Down's syndrome locus to 21q22.3 (Korenberg et al., 
1990). Almost all Down's syndrome patients past the age 
of 35 develop AD-like pathology (NFT and senile plaques) 
in the brain. One putative locus segregating with the early 
onset of familial AD phenotype in some pedigrees has 
also been identified in the region 21q11.2-21q22.2 (St 
George-Hyslop et al., 1987). The 13-APP also undergoes 
phosphorylation on its C-terminal cytoplasmic domain by 
protein kinase C and Ca/CaMII kinase, leading to its de- 
tachment from cytoskeletal components and possible in- 
creased vulnerability to proteolysis (Gandy et al., 1988; 
Refolo et al., 1991). Speculatively, a gene duplication 
event involving the p493F12 kinase could lead to its overex- 
pression and abnormal phosphorylation in the brains of 
Down's syndrome patients. In the case of the familial AD 
patients, possible mutational events or overexpression of 
the p493F12 kinase could also result in aberrant function. 
We have described the cloning and partial characteriza- 
tion of a novel neuron-specific MAP kinase. The mRNA 
is expressed in a subset of neurons in the human hip- 
pocampus and neocortex. The protein colocalizes with 
ALZ-50 in AD-vulnerable neurons in the hippocampus, and 
the gene is located on 21q21, a region that is implicated 
in AD and Down's syndrome pathogenesis. The kinase 
may function by phosphorylating neuronal cytoskeletal 
elements or transcription factors in response to specific 
stimuli. 
Experimental Procedures 
Immunohistochemistry 
Human tissues were obtained from Alzheimer's Disease Research 
Consortium of Los Angeles and Orange Counties. Tissue blocks from 
human hippocampus, neocortex, cerebellum, spinal cord, and white 
matter from patients ages 35-56 were snap-frozen at autopsy and 
stored at -90°C. The average postmortem interval was 8 hr for normal 
and 4 hr for AD patients. Cryostat sections (8-10 p.m) were incubated 
sequentially with the primary antibody, biotinylated goat anti-mouse 
IgM, avidin-biotin complex (Vector Labs), and diaminobenzidine. The 
sections were then viewed with an EDGE high resolution microscope 
(EDGE Instruments). 
For double labeling experiments, ections were incubated with the 
first primary antibody, followed by FITC-conjugated goat anti-mouse 
IgM (Cappell Labs). Following two washes in 1 x phosphate-buffered 
solution (PBS), they were incubated sequentially with the second pri- 
mary antibody, biotinylated goat anti-mouse IgM and Texas Red-con- 
jugated streptavidin (Vector Labs). Following washes, the sections 
were mounted in vectashield (Vector Labs) and viewed under epifluo- 
rescence using a double bypass filter for FITC and Texas Red. MAb 
3F12, an IgM, was the generous gift of Dr. Seymour Benzer; MAb 
ALZ-50, also an IgM, was donated by Dr. Peter Davies. 
Immunoblots 
Tissues were homogenized 1:5 (g/ml buffer) using a Dounce teflon 
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homogenizer in 0.1 M phosphate buffer (pH 7.4), 0.1 M NaCI containing 
1% Triton X-100, and 2 p.m phenyl methyl sulfonyl fluoride (PMSF) 
and were centrifuged at 100,000 x g for 30 min. The supernatant was 
then diluted 1:1 with 2x  SDS-sample buffer, boiled for 2 min, and 
fractionated on 10% SDS-polyacrylamide gel. The proteins were elec- 
troblotted onto nitrocellulose filters, blocked in 4% dry milk in 0.1% 
Triton X-100-PBS (-IPBS), and incubated overnight with antibody di- 
luted in TPBS at 4°C. Following washes, blots were sequentially incu- 
bated with biotinylated secondary antibody, streptavidin-biotin- 
horseradish peroxidasa (HRP) complex and aminoethylcarbazol. For 
immunoaffinity chromatography, anti-p49 (IgG) was purified on Avid-AI 
beads (UniSyn Technologies) and bound to Affigel-10 agarose ac- 
cording to the protocol of the manufacturer (BioRad Laboratories). 
The supernatant from human hippocampal homogenates prepared as 
above was incubated with beads overnight at 4°C followed by washes 
in homogenization buffer. The proteins were then eluted from the 
beads by boiling in 2x SDS sample buffer and analyzed on Western 
blots. 
Construction of Human Hippocampus cDNA Library 
RNA from adult human hippocampus was prepared by the guanidine 
isothiocyanate acid-phenol method (Chomczynski and Sacchi, 1987). 
Poly(A) ÷ mRNA was isolated by two rounds of oligo(dT) cellulose chro- 
matography. The construction of an oligo(dT)-primed cDNA library fol- 
lowed the method of Gubler and Hofmann (Sambrook et al., 1989), with 
some modifications. The cDNA was ligated into dephosphorylated, 
EcoR1 cut ~.ZAPII arms and packaged in vitro. 
cDNA Cloning and DNA Sequencing 
MAb 3F12 was used for immunoscreening a random-primed human 
hippocampal Xgtl 1 expression library (CIontech). Positive clones were 
plaque purified, and inserts were excised by EcoRI restriction diges- 
tion. The insert from clone HH3 was then labeled with ~P by random 
hexamer priming and used to screen the XZAPII human hippocampal 
cDNA library under high stringency conditions. Positive clones were 
plaque purified. To obtain plasmids from isolated phage clones, 
phagemid rescues were performed using the excision protocol. The 
DNA sequences of the clones were determined using the sequenase 
system (United States Biochemical). Both strands were sequenced in 
their entirety. 
The DNA sequence and its deduced amino acid sequence were 
compared with contents of the GenBank DNA and the Swiss-Pro pro- 
tein databases using the FASTA and the TFASTA and BLAST pro- 
grams, respectively. The comparisons were performed using the se- 
quence analysis programs from the University of Wisconsin Genetics 
Computer Group for the VAX/VMS system (Devereux et al., 1984). 
In Situ Hybridization 
Human hippocampal sections were cut and fixed in 40/o paraformalde- 
hyde, washed in 1 x PBS for 15 min at room temperature, and exposed 
to acetic anhydride (0.25O/o [v/v] in 0.1 M triethanolamine [pH 8]). The 
sections were washed twice with 2x SSC, dehydrated through in- 
creasing concentrations of ethanol, and air dried. The sections were 
overlaid with 30-50 ng of p49 z~12 kinase ~P-labeled cRNA probe in 30 
Id of hybridization buffer containing 5 x SSC, 5 x Denhart's solution, 
50% formamide, 100 pg/ml of heat denatured salmon sperm DNA, 
20 I~g/ml of yeast tRNA (Sigma), and 10% Dextran sulfate. Sections 
were coverslipped and placed in a humidified incubator overnight at 
37°C. Coverslips were removed, and the slides were washed in 0.2 x 
SSC at 50°C and 60°C for 1 hr each. The sections were dehydrated 
in ethanol, coated with Kodak NTB-2 emulsion, and exposed in the 
dark at 4°C. After 10 days, the slides were developed and counter- 
stained with Giemsa. 
Northern Blot Analysis 
Total cellular RNA was prepared from postmortem human tissue by the 
guanidinium isothiocyanate acid phenol method (Chomczynski and 
Sacchi, 1987). Poly(A) + mRNA (5 p.g) was fractionated on glyoxal/di- 
methyl sulfoxide gels and transferred to Nytran membranes (Schleicher 
and Schuell). RNA was UV cross-linked, and the membrane was air 
dried. Filters were prehybridized in 6x SSPE, 10x Denhart's, 50% 
formamide, 1% SDS, and 200 p.g/ml of denatured salmon sperm DNA. 
32P-labeled p493F12 cDNA (10-50 ng; first 1000 bp) probe was added 
to the prehybridization mixture, followed by overnight incubation at 
37°C. Washes were carried out in 0.1 x SSC at 65°C. Filters were 
placed on enhancing screens (Cronex, Dupont) and exposed to X-ray 
film at -70°C for 3-7 days for p493F~2 and 12 hr for ~-actin. 
Expression and Purification of 3F12 MAP Kinase 
The 3F12 MAP kinase cDNA was cloned into the PstI-Kpnl sites of 
the pTrcHis A expression vector (Invitrogen). The construct was trans- 
formed into E. coil, and the fusion protein was expressed and purified 
on a Ni-NTA column as per the instructions of the manufacturer (Qia- 
gen). The resultant fusion protein contained a 6x  histidine tag, an 
enterokinase cleavage site, and the 3F12 MAP kinase from amino 
acid 8-422. 
Kinase Assays 
Autophosphorylation was performed by incubating the 3F12 MAP ki- 
nase fusion protein in kinase buffer (25 mM HEPES, 10 mM MgCI2, 
2 mM MnCI2, 1 mM dithiothreitol [pH 7.5], and 100 ~M [y-32P]ATP) at 
30°C for 1 hr (Seger et al., 1991). The reaction was terminated by 
adding SDS electrophoresis ample buffer and heating to 100°C for 
3 min. The phosphorylated fusion protein was separated by electropho- 
resis on a 9% SDS-polyacrylamide gel, blotted onto a polyvinylidine 
difluoride membrane, and detected by autoradiography on Kodak 
X-OMAT AR film. 
3F12 MAP kinase fusion protein was treated as described above, 
except unlabeled ATP was substituted for labeled ATP. The membrane 
was blocked with 5% bovine serum albumin for 1 hr, incubated with 
a 1:1000 dilution of anti-phosphotyrosine (Sigma), and washed with 
PBS/0.1% Tween 20. The membrane was then incubated with horse- 
radish peroxidase-conjugated anti-mouse IgG, washed, and visual- 
ized with 1-chloro-naphthol. Phosphoamino acid analysis was done 
as previously decribed (Crews et al., 1991). 
Genomic Cloning and FISH 
A human ;~Fixll (Stratagene) placenta genomic library was screened 
with 32P-labeled 2.4 kb cDNA probe. A clone with an insert size of 
approximately 12.5 kb with multiple internal EcoRI sites was isolated. 
The EcoRI fragments were gel purified on low melt agarose and labeled 
with biotin by nick translation. 
For FISH, slides with metaphase spreads were denatured in 2 x 
SSC, 70% formamide at 70°C for 2 min and dehyrated in 70% and 
950/0 ethanol for 2 rain each (Trask, 1991). The slides were then hybrid- 
ized overnight at 37°C in buffer containing 2 x SSC, 50% formamide, 
200 I~g/ml of sheared salmon sperm DNA, 200 ng of biotin-labeled 
3F12 genomic DNA, and 100 ng of a biotinylated cosmid probe specific 
for human chromosome 21 telomeric sequences (Oncor). After hybrid- 
ization, slides were washed at 72°C in 2 x SSC for 5 rain, equilibrated 
in 1 x PBS, and incubated with streptavidin-FITC (Zymed) for 1 hr at 
room temperature. Following washes in 1 x PBS, slides were mounted 
in 50 p.I of antifade solution containing 25 mg/ml of triethylenediamine, 
50% glycerol, and 200 ng/ml of propidium iodide in 1 x PBS. The 
slides were viewed under fluorescence and photographed using the 
Oncor FISH image analysis system. The location of the p493F12 gene 
was determined by the measurement of the distance from the most 
proximal portion of the short arm of chromosome 21 to the location 
of the hybridized probe. The relative location of the hybridized probe 
was then determined on a map of human chromosome 21 from human 
gene map 10. 
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Note Added in Proof 
The kinase SAPkb reported by Kyriakis et al. (1994) is probably the 
rat homolog of the p493F12. This kinase displays a 980/o amino acid 
identity with the human p493F~2 kinase. It also shows 98% amino acid 
identity with the mouse homolog of p49 (unpublished data). JNK-1 is 
also a member of this subfamily (Derijard et al., 1994). 
